Table 1 Characteristics of included studies
References | Intervention | Study design | Quality rating (%) | Country | Clinical setting |
|---|---|---|---|---|---|
ePREMs only | |||||
DeRosis [4] | ePREM | Qualitative | 20 | Italy | General hospital |
ePROMs only | |||||
Fredericksen [24] | ePROM | Qualitative | 100 | USA | Community health |
Nielsen [26] | ePROM | Qualitative | 100 | Denmark | Gastroenterology |
Rotenstein [38] | ePROM | Qualitative | 100 | USA | Oncology |
Taliercio [43] | ePROM | Qualitative | 100 | USA | Dermatology |
Unsworth [29] | ePROM | Qualitative | 100 | UK | Counselling/psychotherapy |
Zhang [30] | ePROM | Qualitative | 100 | USA | Orthopaedic and oncology |
Spaulding [28] | ePROM | Qualitative | 93 | USA | Psychiatry |
Kwan [7] | ePROM | Qualitative | 80 | USA | General clinical practice |
Papuga [9] | ePROM | Qualitative | 60 | USA | Orthopaedics |
Schepers [8] | ePROM | Qualitative | 60 | Netherlands | Paediatric oncology |
Trautmann [39] | ePROM | Qualitative | 60 | Germany | Oncology |
Short [27] | ePROM | Observational quantitative | 73 | Canada + USA | Community outpatients |
Li [37] | ePROM | Observational quantitative | 60 | Canada | Oncology |
Bärlund [42] | ePROM | Observational quantitative | 40 | Finland | Oncology |
Hanmer [40] | ePROM | Observational quantitative | 40 | USA | Paediatrics |
Teela [35] | ePROM | Mixed methods | 100 | Netherlands | General hospital |
Burton [32] | ePROM | Mixed methods | 93 | USA | General hospital |
Duman-Lubberding [34] | ePROM | Mixed methods | 93 | Netherlands | Oncology |
Dronkers [33] | ePROM | Mixed methods | 86 | Netherlands | Oncology |
Amini [31] | ePROM | Mixed methods | 80 | Netherlands | General clinical practice |
Howell [36] | ePROM | Mixed methods | 60 | Canada | Oncology |
Bhatt [41] | ePROM | Mixed methods | 20 | USA | Orthopaedics |
ePROM + ePREM | |||||
Krawczyk [25] | ePROM + ePREM | Qualitative | 100 | Canada | Palliative care |